Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Neurobiol Aging. 2022 May 28;117:128–138. doi: 10.1016/j.neurobiolaging.2022.05.009

Table 1.

Demographic and clinical characteristics of the participants.

Characteristics
N 738
Age at death, y (SD) 90.6 (6.4)
Male, n (%) 205 (27.8)
Education, y (SD) 15.7 (3.5)
Median time between last clinical evaluation and death, y 0.65
Antemortem clinical diagnosisa
 No cognitive impairment 226 (30.6)
 Mild cognitive impairment 167 (22.6)
 Dementia 345 (46.8)
Mini-Mental State Examinationa (MMSE), mean (SD) 19.4 (9.7)
At least one copy of the ε4 allele, n (%) 199 (27.0)
Left hemisphere, n (%) 414 (56.1)
Postmortem interval to fixation, h (SD) 9.9 (7.8)
Postmortem interval to imaging, d (SD) 36.4 (15.9)
Scanner for ex vivo MRI, n (%)
 3T GE Signa 51 (6.9)
 3T Siemens Trio 62 (8.4)
 3T Philips Achieva 263 (35.6)
 3T Siemens Verio 362 (49.1)
a

Proximate to death